Antagonists of Protein–Protein Interactions Made Easy?

This publication has 10 references indexed in Scilit:

• Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
  Journal of Medicinal Chemistry, 2012
• Rational Design of Proteolytically Stable, Cell-Permeable Peptide-Based Selective Mcl-1 Inhibitors
  Journal of the American Chemical Society, 2012
• Targeting Mcl-1 for the therapy of cancer
  Expert Opinion on Investigational Drugs, 2011
• A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
  Cell Death & Disease, 2010
• The rise of fragment-based drug discovery
  Nature Chemistry, 2009
• Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family
  Cell Death & Differentiation, 2007
• Apoptosis-based therapies for hematologic malignancies
  Blood, 2005
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours
  Nature, 2005
• Cell Death
  Cell, 2004
• Discovering High-Affinity Ligands for Proteins: SAR by NMR
  Science, 1996